Maven Securities LTD Heron Therapeutics, Inc. Transaction History

Maven Securities LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$30.0 - $40.85 $1.54 Million - $2.09 Million	-51,200 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$26.4 - $42.0 $368,438 - $586,152	13,956 Added 37.47%	51,200 $2.03 Million
Q1 2018 May 15, 2018	BUY	$18.43 - $28.8 $686,406 - $1.07 Million	37,244 New	37,244 $1.03 Million

168

119M

151K

103K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $341M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.